Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Truist Securities Maintains Buy on Sangamo Therapeutics, Lowers Price Target to $19
Truist Securities analyst Nicole Germino maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and lowers the price target from $23 to $19.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Sangamo Therapeutics: Q4 Earnings Insights
Sangamo Therapeutics (NASDAQ:SGMO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Sangamo Therapeutics Q4 EPS $(0.26) Beats $(0.34) Estimate, Sales $27.99M Beat $26.82M Estimate
Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.34) by 23.53 percent. This is a 10.34 percent increase over losses of $(0.29) per share